Author:
Masaki Yoshiaki,Yamada Takeshi,Saneyoshi Hisao,Ohkubo Akihiro,Seio Kohji,Sekine Mitsuo
Publisher
Springer Berlin Heidelberg
Reference48 articles.
1. Aartsma-Rus A, Kaman WE, Bremmer-Bout M et al (2004) Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells. Gene Ther 11:1391–1398
2. Altmann KH, Dean NM, Fabbro D et al (1996) Second generation of antisense oligonucleotides: From nuclease resistance to biological efficacy in animals. Chimia 50:168–176
3. Aoki Y, Yokota T, Nagata T et al (2012) Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery. Proc Natl Acad Sci USA 109:13763–13768
4. Arechavala-Gomeza V, Graham IR, Popplewell LJ et al (2007) Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle. Hum Gene Ther 18:798–810
5. Bordwell FG, Algrim D, Vanier NR (1977) Acidities of anilines and toluenes. J Org Chem 42:1817–1819